Ontak and fatigue Patient Reports February 09, 2010

Ontak Side Effects Report #5663754-2
Ontak side effect was reported by a Physician from UNITED STATES on Feb 25, 2008. Male patient, 69 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Ontak. After drug was administered, patient experienced the following side effects: dyspnoea, fatigue, leukopenia, neutropenia, thrombocytopenia. Ontak dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, PLAVIX, TOPROL, ASPIRIN. Patient recovered.

Ontak Side Effects Report #6121261-7
Ontak side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 2009. Female patient, 28 years of age, weighting 299.8 lb, was diagnosed with lymphoma  and was treated with Ontak. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase abnormal, fatigue, myalgia, myositis . Ontak dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient recovered.

Ontak Side Effects Report #4835161-3
Ontak side effect was reported by a Physician from UNITED STATES on Oct 26, 2005. Female patient, 42 years of age, was diagnosed with adult t-cell lymphoma/leukaemia and was treated with Ontak. After drug was administered, patient experienced the following side effects: blood calcium increased, depressed level of consciousness, fatigue, hepatomegaly, lymphoma , malignant neoplasm progression, rash , white blood cell count increased. Ontak dosage: unknown. Patient was hospitalized. Patient recovered.

Ontak Side Effects Report #5586199-2
Ontak side effect was reported by a Health Professional from UNITED STATES on Dec 24, 2007. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: back pain , bradycardia, cardio-respiratory arrest, dyspnoea, fatigue, musculoskeletal pain, pain in extremity, pain in jaw, sinus tachycardia. Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS INFUSION. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA. Patient was hospitalized. Patient died on 12/19/2007.


Ontak Side Effects Report #5599265-2
Ontak side effect was reported by a Health Professional from UNITED STATES on Jan 03, 2008. Female patient, 45 years of age, weighting 280.0 lb, was treated with Ontak. After drug was administered, patient experienced the following side effects: bradycardia, cardio-respiratory arrest, dyspnoea, fatigue, musculoskeletal pain, sinus tachycardia, unresponsive to stimuli. Ontak dosage: 1620 MG, 2 IN 21 D, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, NEULASTA, NORGESTIMATE, ETINOL, PRILOSEC. Patient was hospitalized. Patient died on 12/19/2007.